Rachel Halpern1, Jerald Seare1, Junliang Tong1, Ann Hartry2, Anthony Olaoye3, Myrlene Sanon Aigbogun4. 1. Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota. 2. Health Economics and Outcomes Research, Lundbeck LLC, Deerfield, Illinois. 3. Business Analytics, Otsuka America Pharmaceuticals, Princeton, New Jersey. 4. Health Economics and Outcomes Research, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
Abstract
BACKGROUND: Agitation is a common neuropsychiatric symptom of Alzheimer disease (AD). Data are scarce regarding agitation prevalence among community-dwelling patients with AD. OBJECTIVE: To estimate agitation prevalence in a sample of US patients with AD/dementia overall and by AD/dementia disease severity, using data from electronic health records (EHR). METHODS: This retrospective database study examined community-dwelling patients with ≥1 EHR record indicating AD/dementia from January 2008 to June 2015 and no evidence of non-Alzheimer dementia during the 12-month preindex and postindex periods. Agitation was identified using diagnosis codes for dementia with behavioral disturbance and EHR abstracted notes records indicating agitation symptoms compiled from the International Psychogeriatric Association provisional consensus definition. RESULTS: Of 320 886 eligible patients (mean age, 76.4 y, 64.7% female), 143 160 (44.6%) had evidence of agitation during the observation period. Less than 5% of patients with agitation had a diagnosis code for behavioral disturbance. The most prevalent symptom categories among patients with agitation, preindex and postindex, were agitation (31.4% and 41.3%), falling (22.6% and 21.7%), and restlessness (18.3% and 23.3%). Among the 78 827 patients (24.6%) with known AD/dementia severity, agitation prevalence was 61.3%. Agitation during the observation period was most prevalent for moderate-to-severe and severe AD/dementia (74.6% and 68.3%, respectively) and lowest for mild AD/dementia (56.4%). CONCLUSIONS: Agitation prevalence was 44.6% overall and 61.3% among patients with staged AD/dementia. Behavioral disturbance appeared to be underdiagnosed. While agitation has previously been shown to be highly prevalent in the long-term care setting, this study indicates that it is also common among community-dwelling patients.
BACKGROUND:Agitation is a common neuropsychiatric symptom of Alzheimer disease (AD). Data are scarce regarding agitation prevalence among community-dwelling patients with AD. OBJECTIVE: To estimate agitation prevalence in a sample of US patients with AD/dementia overall and by AD/dementia disease severity, using data from electronic health records (EHR). METHODS: This retrospective database study examined community-dwelling patients with ≥1 EHR record indicating AD/dementia from January 2008 to June 2015 and no evidence of non-Alzheimer dementia during the 12-month preindex and postindex periods. Agitation was identified using diagnosis codes for dementia with behavioral disturbance and EHR abstracted notes records indicating agitation symptoms compiled from the International Psychogeriatric Association provisional consensus definition. RESULTS: Of 320 886 eligible patients (mean age, 76.4 y, 64.7% female), 143 160 (44.6%) had evidence of agitation during the observation period. Less than 5% of patients with agitation had a diagnosis code for behavioral disturbance. The most prevalent symptom categories among patients with agitation, preindex and postindex, were agitation (31.4% and 41.3%), falling (22.6% and 21.7%), and restlessness (18.3% and 23.3%). Among the 78 827 patients (24.6%) with known AD/dementia severity, agitation prevalence was 61.3%. Agitation during the observation period was most prevalent for moderate-to-severe and severe AD/dementia (74.6% and 68.3%, respectively) and lowest for mild AD/dementia (56.4%). CONCLUSIONS:Agitation prevalence was 44.6% overall and 61.3% among patients with staged AD/dementia. Behavioral disturbance appeared to be underdiagnosed. While agitation has previously been shown to be highly prevalent in the long-term care setting, this study indicates that it is also common among community-dwelling patients.
Authors: Kaitlin R McManus; Maria I Lapid; Brent P Forester; Martina Mueller; Adriana P Hermida; Louis Nykamp; David G Harper; Stephen J Seiner; Sohag Sanghani; Regan Patrick; Melanie T Gentry; Simon Kung; Janette C Leal; Emily K Johnson; Georgios Petrides Journal: J ECT Date: 2022-03-01 Impact factor: 3.692
Authors: Philip Scheltens; Bart De Strooper; Miia Kivipelto; Henne Holstege; Gael Chételat; Charlotte E Teunissen; Jeffrey Cummings; Wiesje M van der Flier Journal: Lancet Date: 2021-03-02 Impact factor: 79.321
Authors: Kamber L Hart; Amelia M Pellegrini; Brent P Forester; Sabina Berretta; Shawn N Murphy; Roy H Perlis; Thomas H McCoy Journal: Gen Hosp Psychiatry Date: 2020-11-10 Impact factor: 3.238
Authors: Willem S Eikelboom; Ellen Singleton; Esther van den Berg; Michiel Coesmans; Francesco Mattace Raso; Rozemarijn L van Bruchem; Jeannette A Goudzwaard; Frank Jan de Jong; Marc Koopmanschap; Tom den Heijer; Jan J M Driesen; Lilian J H M Vroegindeweij; Elsbeth C Thomeer; Susanne E Hoogers; Anke A Dijkstra; Sytse U Zuidema; Yolande A L Pijnenburg; Philip Scheltens; John C van Swieten; Rik Ossenkoppele; Janne M Papma Journal: Alzheimers Res Ther Date: 2019-05-24 Impact factor: 6.982
Authors: J Matthew Brennan; Martin B Leon; Paige Sheridan; Isabel J Boero; Qinyu Chen; Angela Lowenstern; Vinod Thourani; Sreekanth Vemulapalli; Kevin Thomas; Tracy Y Wang; Eric D Peterson Journal: J Am Heart Assoc Date: 2020-08-11 Impact factor: 5.501
Authors: Se Jong Oh; Hae-June Lee; Ye Ji Jeong; Kyung Rok Nam; Kyung Jun Kang; Sang Jin Han; Kyo Chul Lee; Yong Jin Lee; Jae Yong Choi Journal: Sci Rep Date: 2020-09-23 Impact factor: 4.379